Some International Approaches to Aminoglycoside Monitoring in the Extended Dosing Interval Era
Assessment of Interlaboratory Performance in the Provision of Perhexiline Therapeutic Drug Monitoring Services in Australia
Non Steady State and Steady State PKS Bayesian Forecasting and Vancomycin Pharmacokinetics in ICU Adult Patients
Determination of Indinavir in Plasma by Solid-phase Extraction and Column Liquid Chromatography
Determination of Sparfloxacin in Plasma and Urine by a Simple and Rapid Liquid Chromatographic Method
Reversed-phase Ion-pair HPLC Method for the Direct Analysis of 1-OH Midazolam Glucuronide in Human Serum
Effect of Heating Human Sera at a Temperature Necessary to Deactivate Human Immunodeficiency Virus on Measurement of Free Phenytoin, Free Valproic Acid, and Free Carbamazepine Concentrations
Therapeutic Drug Monitoring in Antituberculosis Chemotherapy
COCAINE ANAESTHESIA DURING TOPICAL ANAESTHESIA FOR FUNCTIONAL ENDOSCOPIC SINUS SURGERY
STABILITY OF THERAPEUTIC DRUGS ON SERUM SEPARATOR TUBES FROM BECTON-DICKINSON CONTAINING A NEW GEL FORMULATION.
DEVELOPMENT OF A HIGH-THROUGHPUT DRUG ANALYSIS SYSTEM COMPOSED OF ON-LINE SOLID-PHASE-EXTRACTION WITH MASS SPECTROMETRIC DETECTION
THERAPEUTIC DRUG MONITORING IN VETERINARY MEDICINE - STATE OF THE ART.
THERAPEUTIC DRUG MONITORING (TDM) SERVICES IN DEVELOPING COUNTRY.
PERFORMANCE OF THE QUINIDINE, LIDOCAINE, FREE PHENYTOIN, AND FREE VALPROIC ACID FP ASSAYS ON THE COBAS® INTEGRA 400 ANALYZER.
NEW REAGENT FORMULATIONS APPLIED TO THE COBAS® INTEGRA 700 CLINICAL CHEMISTRY ANALYZER FOR TOXICOLOGY AND TDM ASSAYS.
THERAPEUTIC DRUG MONITORING SERVICES IN A TERTIARY CARE CENTRE -A FIVE YEAR REVIEW.
SEVERE PROTEIN-CALORIE MALNUTRITION REPERCUSSIONS ON THE BIOTRANSFORMATION (PHASE I AND PHASE II REACTIONS) AND EXCRETION OF DRUGS IN PEDIATRIC PATIENTS.
EVALUATION OF PHARMACOKINETIC PARAMETERS ESTIMATED BY THE BAYESIAN METHOD.
PRELIMINARY STUDY OF PHYSICIANS' RESPONSE AND PATIENT OUTCOME TO PHARMACIST RECOMMENDATION OF THERAPEUTIC DRUG MONITORING
KETAMINE AND NORKETAMINE PLASMA LEVEL AFTER ORAL KETAMINE THERAPY.
CONSOLIDATION IN THE DRUG ASSAY LABORATORY THROUGH THE USE OF ALTERNATIVE REAGENTS ON THE HITACHI 917 ANALYZER
UTILIZATION OF LABORATORY SERVICES
CORRELATION BETWEEN HEPATIC VENO-OCCLUSIVE DISEASE (VOD) AND BUSULPHAN LEVELS USING LIMITED SAMPLING MODEL FOR DOSE ESTIMATION.
INCREASED EXPRESSION OF THE MULTIDRUG RESISTANCE PROTEIN AND MODULATION OF DOXORUBICIN INDUCED CYTOTOXICITY FOLLOWING PRE-TREATMENT WITH BENZO(α)PYRENE IN THE CARCINOMA CELL LINE KB-3-1
PHARMACOKINETICS OF METHOTREXATE (MTX) IN SERUM AND CSF AFTER OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION (BBBD) IN PATIENTS WITH BRAIN LYMPHOMA.
MONITORING GUIDELINES OF AMIFOSTINE IN THE PEDIATRIC POPULATION: RESULTS OF A PHASE I/II TRIAL OF ICE WITH AMIFOSTINE
ANTITUMOUR ACTIVITY OF COLCHICINE DERIVATIVES
REGULATION OF SEPIA ON THE DISORDERED ATP METABOLISM IN H22CANCER CELLS
BAYESIAN ESTIMATION OF PHARMACOKINETIC PARAMETERS OF HIGH DOSE METHOTREXATE IN OSTEOSARCOMA PAEDIATRIC PATIENTS.
LARGE VARIABILITY AND SLOW ELIMINATION OF METHOTREXATE IN CEREBROSPINAL FLUID AFTER INTRATHECAL INJECTION
The influence of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval effect on therapeutic efficacy and toxicity.
PHARMACOKINETIC STUDIES OF ATUOFLUODINUM
THE PHARMACOKINETICS OF TOTAL AND FREE MYCOPHENOLIC ACID IN ADULT RENAL TRANSPLANT RECIPIENTS.
PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF FREE AND TOTAL MYCOPHENOLIC ACID IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS:
EFFECT OF MYCOPHENOLIC ACID AND ITS METABOLITES ON TNF-α, IL-1β, AND IL-6 LIBERATION FROM HUMAN MONONUCLEAR LEUKOCYTES
MPA/MPAG LEVELS DURING IV MYCOPHENOLATE MOFETIL (CELLCEPT®) PROPHYLAXIS FOR ACUTE GVHD IN BMT/SCT RECIPIENTS.
CLINICALLY SPECIFIC SPARSE SAMPLING METHOD FOR THE EVALUATION OF CYCLOSPORINE A(CyA) EXPOSURE IN STABLE KIDNEY TRANSPLANTATION.
MEASURING CYCLOSPORIN AUC AFTER NEORAL® USING LIMITED SAMPLING - WEIGHTED OR UNWEIGHTED LINEAR REGRESSION?
THERE IS A ROLE FOR THE TDM OF PREDNISOLONE.
BAYESIAN PHARMACOKINETIC ESTIMATION OF ORAL CICLOSPORINE AND MYCOPHENOLATE CO-ADMINISTERED IN STABLE KIDNEY TRANSPLANT PATIENTS.
METABOLISM AND PHARMACOKINETICS OF THE NEW IMMUNOSUPPRESSANT 40-O-(2-HYDROXY)-ETHYL-RAPAMYCIN
PHARMACODYNAMIC ASSAYS FOR THE IMMUNOSUPPRESSIVE EFFECT OF MPA: DIFFERENT WHOLE BLOOD LYMPHOCYTE FUNCTION ASSAYS AND THEIR CORRELATION WITH GRAFT HISTOLOGY
EVALUATION OF ONE YEAR TREATMENT WITH MYCOPHENOLATE MOFETIL, TACROLIMUS AND CORTICOIDS ON IMPDH ACTIVITY IN RENAL TRANSPLANT PATIENTS.
TIME COURSE OF THE INHIBITION OF CYCLOSPORIN OR TACROLIMUS METABOLISM BY DILTIAZEM.
FOUR-YEAR CONTROL OF A CLINICAL RAPAMYCIN ASSAY
ANALYSIS OF WHOLE BLOOD TACROLIMUS CONCENTRATIONS IN LIVER TRANSPLANT PATIENTS EXHIBITING CHOLESTASIS WITH THE PRO-TRAC™ II ELISA.
THERAPEUTIC WINDOW OF TACROLIMUS IN LIVER TRANSPLANTATION
PHARMACOKINETICS OF TACROLIMUS DURING THE EARLY PHASE AFTER LIVER TRANSPLANTATION
CYCLOSPORIN AND TACROLIMUS. SIMULTANEOUS MEASUREMENT IN WHOLE BLOOD EXTRACTS BY LC-MS/MS.
WITHIN-CENTRE EXTERNAL PROFICIENCY TESTING FOR THE MEASUREMENT OF SIROLIMUS
A CASE REPORT OF POSTMORTEM IMMUNO-SUPPRESSANT CONCENTRATIONS
PLASMA LEVELS OF MYCOPHENOLIC ACID AFTER ORAL MYCOFENOLAT MOFETIL IN PATIENTS AT HIGH RISK FOR GRAFT VERSUS HOST DISEASE (GVHD) AFTER BONE MARROW TRANSPLANTATION
A PRELIMINARY STUDY OF CYCLOSPORINE TDM IN RENAL TRANSPLANT THAI PATIENTS AT SRINAGARIND HOSPITAL.
TIME DEPENDENT CHANGES IN THE KINETICS OF MYCOPHENOLIC ACID (MPA) AFTER ORAL ADMINISTRATION OF MYCOPHENOLATE MOFETIL IN LIVER TRANSPLANT PATIENTS.
USE OF PRIMARY CULTURES OF HUMAN HEPATOCYTES FOR EVALUATING PHASE 2 METABOLISM USING MYCOPHENOLIC ACID.
PHARMACOKINETICS OF TACROLIMUS DOES NOT CHANGE WITH TIME AFTER TRANSPLANTATION IN LIVER TRANSPLANT PATIENTS.
THE INTERNATIONAL MYCOPHENOLIC ACID PROFICIENCY TESTING SCHEME
FEASIBILITY OF AN INTERNATIONAL PROFICIENCY TESTING SCHEME FOR SIROLIMUS
EXTRAHEPATIC GLUCURONIDATION OF MYCOPHENOLIC ACID IN HUMAN GUT AND KIDNEY
TACROLIMUS DRUG INTERACTIONS IN CARDIOTHORACIC TRANSPLANT RECIPIENTS.
MYCOPHENOLIC ACID PLASMA LEVELS AND CLINICAL EFFICACY OR TOXICITY OVER TWO YEARS IN RENAL TRANSPLANT PATIENTS OF A MULTICENTRE CLINICAL TRIAL
VARIABLES AFFECTING TACROLIMUS PHARMACOKINETICS IN PEDIATRIC LIVER TRANSPLANT PATIENTS ON RESCUE THERAPY
SIMULTANEOUS DETERMINATION OF TACROLIMUS AND SIROLIMUS BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (HPLC-MS/MS).
FREE MYCOPHENOLIC ACID DETERMINATION BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (HPLC-MS/MS).
EVALUATION OF A MICROPARTICLE ENZYME IMMUNOASSAY (MEIA) FOR WHOLE BLOOD SIROLIMUS DETERMINATION IN RENAL TRANSPLANT RECIPIENTS.
THE ANALYTICAL PERFORMANCE OF HPLC-TANDEM MASS SPECTROMETRY (LC-MS) AND MICROPARTICLE ENZYME IMMUNOASSAY (MEIA) FOR SIROLIMUS WHOLE BLOOD MEASUREMENT.
COMPARISON OF HPLC-TANDEM MASS SPECTROMETRY (LC-MS) AND MICROPARTICLE ENZYME IMMUNOASSAY (MEIA) FOR THE DETERMINATION OF WHOLE BLOOD TACROLIMUS IN HEART AND LUNG TRANSPLANT PATIENTS.
DILTIAZEM-TACROLIMUS PHARMACOKINETIC INTERACTION - DOSE RESPONSE RELATIONSHIP
CYCLOSPORIN PHARMACOKINETICS AND MONITORING IN RHEUMATOID ARTHRITIS
THE POPULATION PHARMACOKINETICS OF TACROLIMUS IN AUSTRALIAN PAEDIATRIC AND ADULT LIVER TRANSPLANT RECIPIENTS.
DISTRIBUTION OF TACROLIMUS IN BLOOD.
EVALUATION OF SPECIFICITY OF MONOCLONAL ANTIBODIES TO SIROLIMUS
A NEW MONOCLONAL ANTIBODY FOR THE IMMUNOSUPPRESSIVE DRUG TACROLIMUS.
DEVELOPMENT OF A FULLY AUTOMATED CSA METHOD FOR THE DIMENSION® CLINICAL CHEMISTRY SYSTEM.
INFLUENCE OF TIME AND COMEDICATION ON PLASMA CONCENTRATION OF MYCOPHENOLIC ACID IN KIDNEY AND LUNG TRANSPLANT PATIENTS.
CONVERSION FROM CYCLOSPORINE TO TACROLIMUS IN RENAL TRANSPLANTATION: THERAPEUTIC MONITORING AND CLINICAL OUTCOME.
INFLUENCE OF TACROLIMUS ON MYCOPHENOLATE MOFETIL METABOLISM IN AN EX VIVO ISOLATED SMALL BOWEL PERFUSION MODEL*
TISSUE DISTRIBUTION OF THE NOVEL MACROLIDE IMMUNOSUPPRESSANT SDZ-RAD: INTERACTION WITH CYCLOSPORINE
A FAST, AUTOMATED, AND SPECIFIC ASSAY TO QUANTIFY CYCLOSPORINE AND MACROLIDE IMMUNOSUPPRESSANTS IN BLOOD USING LC/LC-MSD.
A MULTI-CENTER EVALUATION OF THE RELATIONSHIP OF TACROLIMUS BLOOD LEVELS TO EFFICACY AND TOXICITY IN LIVER TRANSPLANT PATIENTS.
CLINICAL EXPERIENCE WITH TACROLIMUS IN KIDNEY AND LIVER TRANSPLANT RECIPIENTS
DETERMINATION OF IMPDH ACTIVITY IN WHOLE BLOOD: VALIDATION OF OUR ASSAY.
THE TRACE AMOUNT OF MYCOPHENOLIC ACID IN IT'S PHENOLIC GLUCURONIDE EXPLAINS THE WEAK INHIBITION OF IMPDH BY THE METABOLITE.
IMx SIROLIMUS ASSAY PERFORMANCE STUDIES
PREDICTING CYCLOSPORIN AUC AFTER NEORAL® - A COMPARISON OF PUBLISHED SPARSE SAMPLING ALGORITHMS.
SPARSE SAMPLE MEASUREMENT OF CYCLOSPORIN AUC AFTER NEORAL® IN HEART TRANSPLANT PATIENTS.
EFFECT OF ISCHEMIA/REPERFUSION ON MYCOPHENOLIC ACID METABOLISM IN A PIG LIVER MODEL
EVALUATION OF AN EMIT® TACROLIMUS ANTIBODY: COMPARISON WITH PENTAMER FORMATION ASSAY AND TACROLIMUS II MEIA
CYCLOSPORINE DOSE-REGIMEN EVALUATION AND PHARMACOKINETICS
INFLUENCE OF EXTERNAL BILIARY DRAINAGE ON CYCLOSPORINE (NEORAL) ABSORPTION IN A PEDIATRIC LIVER TRANSPLANT RECIPIENT.
Pharmacokinetics of MPA in renal transplant recipients receiving different doses of MMF.
REACTIVITY OF MONOCLONAL ANTIBODIES TO CYCLOSPORINE METABOLITES
CLINICAL PHARMACOKINETICS OF PHENOBARBITAL IN (PREMATURE) NEONATES.
TOPIRAMATE DECREASES LAMOTRIGIN CONCENTRATIONS
COMPARATIVE DRUG MONITORING OF CARBAMAZEPIN SUSPENSION (TROYAPHARM) AND TEGRETOL SYRUP (CIBA GEIGY) IN EPILEPTIC CHILDREN
PHARMACOECONOMIC ANALYSIS OF THERAPEUTIC DRUG MONITORING (TDM) IN ADULT EPILEPTIC PATIENTS
THERAPEUTIC DRUG MONITORING (TDM) AND RESPONSE OF 112 NEUROCYSTICERCOSIS PATIENTS TO ANTICONVULSANTS IN BOMBAY
THE DISPOSITION OF LAMOTRIGINE THROUGHOUT PREGNANCY
IN VITRO MICRODIALYSIS MONITORING OF FREE (NONPROTEIN BOUND) ANTIEPILEPTIC DRUG LEVELS
RAPID BUT IN INCOMPLETE IN VITRO CONVERSION OF FOSPHENYTOIN INTO PHENYTOIN IN SERA OF PATIENTS WITH LIVER DISEASE : ROLE OF ALKALINE PHOSPHATASE.
THE CHANGES OF METABOLISM OF PRIMIDONE DURING CO-MEDICATION WITH PHENYTOIN AND CARBAMEZEPINE.
THE CHANGES OF METABOLISM OF CARBAMAZEPINE DURING CO-MEDICATION WITH PHENYTOIN AND PRIMIDONE.
A RETROSPECTIVE STUDY TESTING THE VALIDITY OF HUSSEIN'S EQUATION FOR ADJUSTING PHENYTOIN DOSAGE REGIMEN.
A TABLE FOR ADJUSTING PHENYTOIN DOSAGE REGIMEN.
AN EQUATION FOR ADJUSTING PHENYTOIN DOSAGE REGIMEN.
A COMPARISON OF THE PERFORMANCE OF DIFFERENT TECHNIQUES FOR THE DETERMINATION OF A ONCE DAILY GENTAMICIN DOSE.
PHARMACOKINETIC PROFILE OF NELFINAVIR (NFV) AND EFAVIRENZ (EFV) IN COMBINATION THERAPY ADMINISTERED TO HIV-1 INFECTED PATIENTS.
SIMULTANEOUS MEASUREMENT BY HIGH PERFORMANCE LIQUID (HPLC) CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION OF FOUR HIV PROTEASE INHIBITORS IN PLASMA FROM HIV INFECTED INDIVIDUALS - APPLICATION TO THERAPEUTIC DRUG MONITORING (TDM).
A NOVEL TEST TO PREDICT SULFONAMIDE HYPERSENSITIVE REACTION IN NORMAL POPULATION AND IN IMMUNOCOMPROMISE SUBJECTS
PHARMACOKINETIC STUDY OF INTRAMUSCULAR ARTESUNATE IN VIETNAMESE PATIENTS WITH FALCIPARUM MALARIA.
CLINICAL AND ECONOMIC BENEFIT BY OPTIMIZED AMINOGLYCOSIDE THERAPY IN NEUTROPENIC PATIENTS WITH FEVER OF UNKNOWN ORIGIN.
PREDICTIVE CAPACITY OF GENTAMICIN POPULATIONAL PHARMACOKINETIC PARAMETERS IN PREMATURE NEONATES
GENTAMICIN KINETIC PROFILE IN VERY LOW BIRTH WEIGHT NEWBORNS
THERAPEUTIC MONITORING OF QUININE IN ADULT MALE PATIENTS WITH NON-SEVERE FALCIPARUM MALARIA.
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) METHOD FOR THE DETERMINATION OF CEFEPIME PLASMA CONCENTRATIONS IN INTENSIVE CARE PATIENTS.
AN ASSESSMENT OF THE ENVIRONMENTAL CONTAMINATION BY AEROSOLIZED TOBRAMYCIN IN A PEDIATRIC PULMONARY UNIT
AN HPLC ASSAY OF INDINAVIR IN SERUM
VANCOMYCIN IN THE NEONATE POPULATION. MULTIPLE REGRESSION ANALYSIS TO INVESTIGATE PREDICTIVE VARIABLE'S THAT WOULD ASSURE THERAPEUTIC THROUGH LEVELS.
MANAGING ANTI-TUBERCULOSIS DRUG THERAPY BY THERAPEUTIC DRUG MONITORING OF ISONIAZID AND RIFAMPICIN.
PHARMACOKINETIC PROFILE OF ISONIAZID, RIFAMPIN AND PYRAZINAMIDE IN PATIENTS WITH TUBERCULOSIS.
PREDICTABILITY OF SERUM VANCOMYCIN CONCENTRATIONS BASED ON THE BAYESIAN METHOD.
SIMULTANEOUS DETERMINATION OF INDINAVIR, RITONAVIR, SAQUINAVIR, AND NELFINAVIR BY HPLC
DETERMINATION OF OPTIMAL DOSAGE OF CIBENZOLINE SUCCINATE CORRESPONDING TO THE PATIENTS WITH VARIOUS RENAL FUNCTIONS
DIGOXIN IMMUNOASSAY PERFORMANCE FROM THE MANUFACTURERS' PERSPECTIVE.
STUDIES ON MEXILETINE DISPOSITION IN MAN.
THE UTILITY OF DIGOXIN ASSAYS IN THE DIAGNOSIS OF DIGOXIN TOXICITY.
COMPARISON OF THE ROCHE ELECSYS® DIGOXIN ASSAY WITH THE CHIRON ACS:180 PLUS
IMPACT OF PRE-HOSPITALIZATION TREATMENT TO DIGOXIN INTOXICATION IN ELDERLY
DOXEPIN SERUM CONCENTRATIONS: IS THERE REALLY A THERAPEUTIC RANGE?
SERUM LEVELS AND SIDE-EFFECTS OF TRICYCLIC ANTIDEPRESSANTS WITH ADJUNCTIVE PAROXETINE. A PROSPECTIVE STUDY.
DEVELOPMENT OF A GAS CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF QUETIAPINE IN HUMAN SERUM, AND A REPORT OF PATIENT VALUES.
MONITORING OF OLANZAPINE IN SERUM BY LIQUID CHROMATOGRAPHY-ATMOSPHERIC PRESSURE CHEMICAL IONIZATION MASS SPECTROMETRY.
Practical Application of Lithium Ion-selective Electrode (ISE) Assay and Population Pharmacokinetic Approach to Therapeutic Drug Monitoring (TDM) Services in Psychiatry
EXCRETION OF NEFAZODONE AND SERTRALINE INTO BREAST MILK - DETERMINED BY HPLC.
OLANZAPINE PHARMACOKINETICS AND DRUG INTERACTIONS: EVIDENCE FROM TDM DATA
BAYSIAN APPROCH FOR ESTIMATING ZUCLOPENTHIXOL STEADY STATE TROUGH CONCENTRATION
BAYESIAN APPROACH FOR ESTIMATING LITHIUM STEADY STATE TROUGH CONCENTRATION
SALBUTAMOL ASSAY AND PHARMACOKINETICS IN ACUTE SEVERE ASTHMA
THERAPEUTIC MONITORING OF 4-METHYL PYRAZOLE IN METHANOL POISONING: ANALYTICAL VALIDATION AND PHARMACOKINETICS.
MONITORING OF THERAPEUTIC OUTCOME OF H.PYLORI ERADICATION THERAPY USING THE 13C-UREA BREATH TEST.
EVALUATION OF DRUGCALC PROGRAM FOR WARFARIN THERAPEUTIC MONITORING
ANALYSIS OF THREE WARFARIN EFFECT MARKERS: PROTHROMBIN TIME, FACTOR X AND FACTOR II.
ANTIMICROBIAL ACTIVITY OF FIXED OIL OF Ocimum sanctum - ITS ROLE IN INFLAMMATORY DISEASES.
CADMIUM CAUSED ECTOPIC PATTERN OF APOPTOSIS DURING ZEBRAFISH EMBRYONIC DEVELOPMENT
IN A CO-CULTURE OF NORMAL HUMAN LIVER STELLATE CELLS AND HEP G2 HORNET VENOM INDUCES APOPTOSIS
THE NOVEL IMMUNOSUPPRESSANT SDZ-RAD ANTAGONIZES CYCLOSPORINE-INDUCED REDUCTION OF BRAIN ENERGY
PHENYTOIN, LIFE-SAVING IN A NORTRIPTYLINE INTOXICATION
ACTIVATED CHARCOAL VS GASTRIC LAVAGE FOLLOWED BY ACTIVATED CHARCOAL IN VOLUNTEERS WITH LARGE TABLETINGESTIONS.
ENTEROSORPTION PROPERTIES OF ZEOLITES IN RATS.
DEVELOPMENT OF A POISON CENTER NETWORK:THE TEXAS EXPERIENCE, PART II:THE FIRST FOUR YEARS
POISONING BY SOUTH AFRICAN TRADITIONAL MEDICINES: IDENTIFICATION OF IMPILA
POISONING BY SOUTH AFRICAN TRADITIONAL MEDICINES : DETECTION OF PYRROLIZIDINE POISONING
ORAL CONTRACEPTIVES INCREASE PLASMA LEVELS OF CHLORPROMAZINE - A CASE REPORT
TOXIC EFFECT OF ASBESTOS FIBRES ON THE SELECTED LUNG PARAMETERS.
EFFECT OF ENVIRONMENTAL LEAD EXPOSURE IN SLOVAK SCHOOL CHILDREN.
NICOTINE AND COTININE DISPOSITION IN CIGARETTE EXTRACT POISONING
pH-DEPENDENT INFLUX AND EFFLUX OF CISPLATIN ACROSS APICAL MEMBRANE OF CULTURED RENAL EPITHELIAL CELLS.
PERFORMANCE OF THE ROCHE (BMC) ETHANOL ASSAY ON THE OLYMPUS AU600 CHEMISTRY ANALYZER.
ISOLATED PERFUSED LUNG AND PRIMARY CULTURE OF LUNG CELLS ARE USEFUL MODELS IN INVESTIGATION OF LUNG-SPECIFIC DRUG METABOLISM
PROVIDING MORE EFFECTIVE TOXICOLOGY SCREENING.
INVESTIGATION OF ADVERCE REACTIONS OF TREATMENT WITH ROSE OIL BY IMMUNE MONITORING OF PATIENTS WITH CHRONIC ACTIVE CHOLECYSTITIS
INVESTIGATION OF THE POISONED PATIENT: A CLINICAL PRACTICE GUIDELINE
THE IMPAIRMENT OF ENERGY METABOLISM OF RAT BRAIN BY DOXORUBICIN
EFFECT OF CHOLINESTERASE INHIBITORS ON COAGULATION TIMES IN VITRO.
KETAMINE DETECTION BY AUTOMATED HPLC SYSTEM
Development of a Toxicant Screening Procedure Using Liquid Chromatography-Electrospray-Mass-Spectrometry (LC-ESMS)
TOXICOLOGICAL FINDINGS IN MIL WAUKEE COUNTY - SELECTED REVIEW FROM 1990 TO 1998
ACUTE ZOLPIDEM OVERDOSE - A CASE REPORT
IMPLEMENTATION OF A URINARY OPIATES TESTING PROGRAMME WITH A 2,000 NG/ML SCREENING AND CONFIRMATION CUT-OFF VALUE
URINE DRUG TESTING FOR SOCIAL SERVICE AGENCIES IN NOVA SCOTIA, CANADA
TOXICOLOGICAL ANALYSIS OF BLOOD SAMPLES OF INJURED DRIVERS
USE OF AN IONSPRAY-TANDEM MASS SPECTROMETRY (MS/MS) LIBRARY FOR DRUG SCREENING
URINE TOXICOLOGY: A PROSPECTIVE COMPARISON OF REMEDI® AND FULL SCAN GC MASS-SPECTROMETRY
SOLID PHASE EXTRACTION OF β2-AGONISTS FROM URINE WITH MOLECULAR IMPRINTS.
FATTY ACID ETHYL ESTERS- A NOVEL BIOLOGICAL MARKER FOR HEAVY IN UTERO ETHANOL EXPOSURE
ABUSE OF GAMMA-HYDROXY BUTYRATE (LIQUID ECSTASY) WITH OTHER STREET DRUGS
COMPARISION OF IMMUNOASSAY DETECTION FOR DRUGS OF ABUSE WITH AUTOMATED HPLC SYSTEM
DETECTION OF GAMMA-HYDROXY BUTYRATE IN URINE AND SERUM BY GC-FID
VALIDATION OF ROCHE ONLINE® DAU REAGENTS ON THE HITACHI 917 ANALYZER.
HAIR ANALYSIS FOR HEROIN AND COCAINE IN A GROUP OF PATIENTS UNDER METHADONE THERAPY.
EFFECTS OF COCAINE ABUSE ON PLASMA HOMOCYSTEINE AND RELATED THIOLS.
URINE DRUG SCREENING BY DADE DIMENSION® WITH GC-MS CONFIRMATION.
PERFORMANCE OF CEDIA® DAU ASSAYS ON THE OLYMPUS AU600 CHEMISTRY ANALYZER.
COMPARISON OF HYDROLYSIS TECHNIQUES FOR THE ESTIMATION OF TOTAL CODEINE AND MORPHINE CONCENTRATIONS IN URINE.
ENANTHIOMERIC SEPARATION OF AMPHETAMINES AFTER THE ADMINISTRATION OF L-DEPRENYL AND METHAMPHETAMINE BY CAPILLARY ELECTROPHORESIS.
SCREENING FOR DRUGS OF ABUSE IN SERUM SAMPLES USING AXSYM FPIA TECHNOLOGY
IMPROVEMENT OF STANDARD IMMUNOASSAY FOR BENZODIAZEPINE TRACES DETECTION IN URINE
PREVALENCE OF CANNABINOID AND COCAINE METABOLITES IN "DILUTE" URINE SPECIMENS
ANALYSIS OF UNDERIVATIZED AMPHETAMINES AND RELATED PHENETHYLAMINES WITH HIGH PRESSURE LIQUID CHROMATOGRAPHY-ATMOSPHERIC PRESSURE CHEMICAL IONIZATION MASS SPECTROMETRY (LC-APCI-MS).
DRUG USE IN SPORT: AUSTRALIAN PERSPECTIVE
ANABOLIC-ANDROGENIC STEROID USERS IN SYDNEY: CORRELATION BETWEEN REPORTED DRUG USE AND DRUG DETECTION IN URINE.
PHARMACOGENETICS: GENOTYPING OF CYTOCHROMES P450 2D6 AND 2C19 IN PSYCHIATRIC PATIENTS TREATED WITH TRICYCLIC ANTIDEPRESSANTS (TCA) OR NEUROLEPTICS.
CYP 2D6 PHENOTYPE IN PATIENTS WITH MAJOR DEPRESSION
Polymorphism of CYP2D6 gene and relationship to diseases in children
DISTRIBUTION OF FcγRIIA GENOTYPES IN PATIENTS WITH ATOPIC DISEASES.
STEADY-STATE SERUM CONCENTRATION TO DOSE RATIOS OF NORTRIPTYLINE IN RELATION TO CYP2D6 GENETIC POLYMORPHISM AS OBSERVED UNDER THERAPEUTIC DRUG MONITORING
DISTRIBUTION AND EXCRETION OF FLUOXETINE AND NORFLUOXETINE IN HUMAN MILK.
METABOLISM, SECRETION AND BILIARY EXCRETION INTO THE HUMAN INTESTINE OF VERAPAMIL STUDIED WITH A PERFUSION CATHETER.
Pharmacokinetics of 6-Thioguanine nucleotides under i.v. Therapy with Azathioprine.
SERUM CONCENTRATIONS OF CLOZAPINE, CLOMIPRAMINE AND THEIR METABOLITES CORRELATED TO THEIR CONCENTRATIONS IN BRAIN
PROGUANIL OXIDATION IN A CHINESE POPULATION
LOW CEFEPIME LEVELS FOUND IN SEPTIC CRITICALLY ILL PATIENTS IMPROVED IN PHARMACOKINETIC SIMULATIONS OF REVISED DOSING.
BUSULFAN-INDUCED NEUROTOXICITY IN PRE-BMT TREATED ADULTS
PHARMACOKINETICS OF ACETYL SALICYLIC ACID AND ITS METABOLITES IN CHILDREN WITH AUTOIMMUNE DISEASE.
RELATIONSHIP BETWEEN PLASMA FENOFIBRIC ACID LEVELS AND THE EFFECT OF MICRONIZED FENOFIBRATE ON CHOLESTEROL, LOW DENSITY LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN B IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA.
PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF LIPOPHILIC DRUG USING A BRAIN COMPARTMENT MODEL
DEGRADATION OF THE 52 kDa MINOR IMMUNOPHILIN INTO 6.5 kDa FRAGMENTS.
FURTHER BIOCHEMICAL CHARACTERIZATION OF THE MINOR IMMUNOPHILINS.
LAMOTRIGINE (LTG) PHARMACOKINETICS DURING DELIVERY AND LACTATION.
SALIX CORTEX(WILLOW BARK DRY EXTRACT) EFFECT ON PLATELET AGGREGATION.
Time-Stratified correlation analysis of Emit and HPLC for TDM of MPA
MPA-AUC models in relation to outcome in pediatric KTx
DISTRIBUTION AND EXCRETION OF CITALOPRAM IN HUMAN MILK.
PHARMACOKINETIC ANALYSIS OF GENTAMICIN IN IMMUNE-COMPROMISED ADULTS: DIFFERENT SINGLE DAILY DOSAGE PROTOCOLS.
IN VITRO METABOLISM OF THE TRICYCLIC ANTIDEPRESSANT DOXEPIN
Hepatic ecNOS and CYP3A4 mRNA expression in chronic pediatric liver failure
VALIDATION OF A SERIES OF MARKERS FOR STUDYING RENAL DRUG ELIMINATION.
MEASUREMENT OF PLASMA PERHEXILINE AND HYDROXY-PERHEXILINE CONCENTRATIONS IN PATIENTS.
THEORETICAL CONSIDERATIONS FOR THE APPLICATION OF MOLECULAR IMPRINTS FOR CHEMICAL ANALYSIS
AFFINITY BIOSENSORS BASED ON A CAPACITIVE TRANSDUCER FOR LOW LEVEL DETECTION OF ANTIGENS
IDENTIFICATION OF MORPHINE IN URINE: THIN LAYER CHROMATOGRAPHY AND FAST ATOM BOMBARDMENT MASS SPECTROMETRY AND TANDEM MASS SPECTROMETRY.
Therapeutic drug monitoring of Haloperidol, Perphenazine and Zuclopenthixol in serum by a totally automated sequential solid phase extration followed by HPLC.
METHYLENEDIOXYAMPHETAMINE (MDA) AND METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY) EXTERNAL QUALITY ASSESSMENT IN URINE DRUG TEST SCREENING.
A SIMPLE HPLC METHOD FOR THE DETERMINATION OF LAMOTRIGINE SERIC CONCENTRATIONS IN EPILEPTIC PATIENTS
Dilution Protocols for AxSYM®, TDx®, and ADx® Opiates Assays Provide Extended Working Ranges
ANALYSIS OF PROTEIN-BOUND AND TOTAL S-2-(3-AMINOPROPYLAMINO)ETHANETHIOL (WR-1065) IN BLOOD BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC).
AN IMPROVED METHOD FOR THE MEASUREMENT OF PAROXETINE IN HUMAN SERUM/PLASMA BY HPLC WITH FLUORESCENCE DETECTION.
COMPARISON OF ELECTROCHEMICAL AND ULTRAVIOLET DETECTION IN AN HPLC ASSAY FOR OLANAZPINE IN PLASMA.
TOXICITY AND ANALYSIS OF GLYCOL ETHERS
TUNING OF THE SELECTIVITY IN CAPILLARY ELECTROPHORESIS BY CYCLODEXTRINS ILLUSTRATED BY THE SEPARATION OF SOME STRUCTURALLY RELATED PHENOTHIAZINES
COMPARISON OF THREE METHODS FOR DETERMINATION OF CYCLOSPORINE-A AND ITS METABOLITES FOR TDM IN THE GROUP OF RENAL TRANSPLANT PATIENTS.
HPLC METHOD OF CYCLOSPORINE A AND ITS TWO METABOLITES FOR TDM IN PATIENTS.
DETERMINATION OF DEXAMETHASONE IN HUMAN AQUEOUS HUMOUR BY LC-MS
DEVELOPMENT OF ANALYTICAL DETECTION METHODOLOGIES FOR CIGUATOXINS.
IMPROVED SENSITIVITY OF DIGOXIN ASSAY BY MODIFICATION OF THE EMIT 2000 METHOD - APPLICATION TO THE PHARMACOKINETIC INTERACTION BETWEEN DIGOXIN AND MACROGOL 4000, A LAXATIVE POLYMER, IN HEALTHY VOLUNTEERS.
COMPREHENSIVE DRUG SCREENING BY INTEGRATED USE OF GC-MS AND REMEDi HS.
PERFORMANCE OF SAMPLE EXTRACTION TECHNIQUES FOR DRUGS OF ABUSE IN URINE
QUANTIFICATION OF NON-DEPOLARIZING MUSCLE RELAXANTS WITH LC-MS-MS
EVIDENCE FOR ALIPHATIC HYDROXYLATION OF BUPIVACAINE IN MAN
Ipecac Toxicity in "Munchausen Syndrome by Proxy"